(Q63318843)
Statements
Eight-week, Multi-centre, Dose-response, Double Blind, Placebo-controlled, Randomized, Parallel-group, PhaseⅡ Trial to Evaluate Efficacy and Safety of SI000413 in Patients With Knee Osteoarthritis (English)
0 references
January 2012
0 references
December 2013
0 references
152
0 references
35 year
0 references
75 year
0 references